NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Injectable Drug Delivery to 2016
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
Highlights
- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication
- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
- Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies
- Forecasts Injectable drug product demand by indication and therapy to 2016• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations Executive Summary
Injectable Drug Delivery Market Dynamics
The Injectable Drug Ecosystem Injectable Drug Demand Drivers Drug Development Factors Market Factors Technology Factors Competitive Landscape Autoinjectors Needle-free Injectors Pen Injectors Prefilled Syringes Safety Syringes Injectable Drug Demand Drivers Diseases and Indications Patient Demographics Developing Economies Risks and Opportunities
Injectable Drug Device Selection Criteria
Stability and Material Selection Issues Single vs Multi-Dose Devices Lyophilized Drugs/Reconstitution Syringe Safety/Sharps Protection Needle Configuration Strategies Disposable Drug Cartridges Human Engineering/Ergonomics Branding/Private Labeling
Injectable Drug Delivery – Device Segments
Autoinjectors Autoinjector-specific Selection Factors Part Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection Confirmation Autoinjector Device Categories Reusable Autoinjectors Disposable Autoinjectors Product Specific Autoinjectors Drugs and Therapeutic Segments
Needle-free Injectors
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source
Injection Site Selection
Pen Injectors Pen Injector Device Categories Standardized Pen Platforms Custom Pen Designs Reusable Pens Prefilled Pen Cartridges Disposable Pens Dual Chamber Pens Branded Drug/Pen Injector Product by Therapeutic Segment
Prefilled Syringes
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS Manufacturing Factors
Fill-and-Finish Operations
Safety Syringes Safety Syringe Device Categories Prefillable Integrated Safety Syringes Non-Prefillable Integrated Safety Syringes Retractable Needle Manually Retractable Automatic Retractable Sliding Sheath
Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts
Anaphylaxis Anticoagulants Antivirals Autoimmune Diseases Emergency Medicine Hematopoietics Hormone Replacement Metabolic Diseases Neurology Reproductive Health Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Factors and Issues FDA Regulations Regulating Combination Products Sharps Legislations Growth and Diversity of Safety Syringes Sharps Disposal Clinical Trial Factors Managed Care and Healthcare Economics
Company Profiles
To order this report: Drug_Delivery_Technology Industry: Injectable Drug Delivery to 2016
Nicolas Bombourg |
Reportlinker |
Email: [email protected] |
US: (805)652-2626 |
Intl: +1 805-652-2626 |
SOURCE Reportlinker
Share this article